Apr 22, 2015, 09:00 ET PLAINSBORO, N.J., April 22, 2015 /PRNewswire/ -- Novo Nordisk today announced that Saxenda (liraglutide [rDNA origin] injection) is now available in the United States
30, 2026 An earlier version of this story mistakenly said that the drug tirzepatide blocks a hormone called GIP
Patients with diabetes may need closer glucose monitoring and clinician-directed adjustments to other diabetes medicines
SURMOUNT-4 will address the question of weight regain after stopping the drug: patients who took tirzepatide for 6 months, will be assessed for sustained weight loss one year later (NCT04660643)
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity
According to drugmaker Eli Lilly , the treatment is intended for use alongside a reduced-calorie diet and increased physical activity